Kidney transplant virus filter trial pulled before start
NCT ID NCT04984902
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a special blood filter (Seraph 100) could reduce BK virus levels in kidney transplant patients with high viral loads. It planned to enroll adults with a BK virus level of 10,000 IU/mL or higher who already had dialysis access. However, the trial was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BK VIREMIA IN KIDNEY TRANSPLANT PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Essen
Essen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine shield transplant patients from shingles?
- Can a single drug dose forecast transplant kidney health?
- Contrast dye Double-Dose: new study tracks kidney fallout in ICU patients
- Pre-Surgery bootcamp may boost kidney transplant recovery
- Could a simple breath test spot hidden diseases early?
- Steroids for kidney disease: do they prevent failure Long-Term?